Godrej Consumer Products Limited (GODREJCP.NS)
Mumbai, IN
Godrej Consumer Products Limited (GCPL) operates as a prominent fast-moving consumer goods (FMCG) enterprise. The company manufactures and distributes a diverse range of personal care and home care solutions across various international markets, including India, Africa, Indonesia, the Middle East, and the United States. Its extensive product portfolio features household items like insecticides, wet wipes, and air fresheners, alongside a broad selection of personal grooming essentials. These include hair colors, soaps, hair extensions, wet hair products, hair relaxers, depilatory items, styling sprays, fabric care, and various personal wash, hygiene, beauty, and professional products. GCPL markets its offerings primarily through a distinguished collection of brands such as Good knight, Godrej Expert, Cinthol, Godrej No. 1, Hit, Darling, Godrej protekt, Godrej aer, TCB Naturals', MegaGrowth, Just For Me, African Pride Moisture Miracle, Millefiori, Issue, Ilicit, Godrej ProClean, Bidex, Inecto, Stella, Mitu, Saniter, Godrej Ezee, Pamela Grant, Renew, NYU, Roby, 919, and Godrej Professional. Established in 1897, the company maintains its corporate headquarters in Mumbai, India.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +1.91% | -3.24% | -4.44% | -14.46% | -9.31% | -15.71% | -20.11% | +3.10% | +18.03% | +114.74% | +24,487.11% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 7 | 0 |
| Buy | 22 | -1 |
| Hold | 5 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 1 | 0 |
-
Revenue growth Household & Personal Products: +3.3%+5.7% ★ Q1'26: +8.4% (vs Q1'25)
-
EPS growth Household & Personal Products: +8.8%+0.4% Q1'26: +9.7% (vs Q1'25)
-
FCF margin FCF growth · Household & Personal Products: +44.8%+12.4% Q1'26: +9.4% (vs Q1'25)
-
EBIT margin Household & Personal Products: +9.9%+19.0% ★ Q1'26: +19.6% (vs Q1'25)
-
ROIC Household & Personal Products: +8.2%+14.6% ★ Q1'26: +14.9% (vs Q1'25)
-
Share dilution Household & Personal Products: +0.2%+0.1% Q1'26: +0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Household & Personal Products: -0.51×1.40× Q1'26: 1.31× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2011 actual |
Mar 2012 actual |
Mar 2013 actual |
Mar 2014 actual |
Mar 2015 actual |
Mar 2016 actual |
Mar 2017 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 29 Rev. Ana. 20 EPS Ana. |
Mar 2027 30 Rev. Ana. 25 EPS Ana. |
Mar 2028 31 Rev. Ana. 28 EPS Ana. |
Mar 2029 11 Rev. Ana. 10 EPS Ana. |
Mar 2030 7 Rev. Ana. 4 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
36.43B
est: 35.52B (+2.6%)
|
48.66B
est: 48.52B (+0.3%)
|
64.16B
est: 64.76B (-0.9%)
|
76.02B
est: 78.09B (-2.6%)
|
82.76B
est: 84.56B (-2.1%)
|
84.24B
est: 89.93B (-6.3%)
|
92.68B
est: 97.34B (-4.8%)
|
98.47B
est: 100.59B (-2.1%)
|
103.14B
est: 105.81B (-2.5%)
|
99.11B
est: 102.40B (-3.2%)
|
110.29B
est: 109.37B (+0.8%)
|
122.77B
est: 122.84B (-0.1%)
|
133.16B
est: 133.26B (-0.1%)
|
140.96B
est: 139.79B (+0.8%)
|
143.64B
est: 143.34B (+0.2%)
|
155.07B
153.44B – 156.51B
+8.2% YoY
|
169.57B
165.73B – 173.09B
+9.4% YoY
|
186.07B
178.81B – 192.83B
+9.7% YoY
|
202.52B
201.39B – 203.66B
+8.8% YoY
|
234.26B
226.94B – 241.04B
+15.7% YoY
|
| EBITDA |
6.94B
est: 5.78B (+20.0%)
|
11.14B
est: 8.43B (+32.2%)
|
10.29B
est: 13.51B (-23.9%)
|
11.97B
est: 12.46B (-3.9%)
|
13.73B
est: 11.18B (+22.8%)
|
16.38B
est: 13.36B (+22.6%)
|
19.01B
est: 13.29B (+43.0%)
|
20.82B
est: 18.47B (+12.7%)
|
21.14B
est: 22.43B (-5.8%)
|
20.98B
est: 21.07B (-0.4%)
|
23.96B
est: 19.78B (+21.1%)
|
24.43B
est: 21.62B (+13.0%)
|
24.84B
est: 23.71B (+4.8%)
|
30.24B
est: 31.59B (-4.3%)
|
29.53B
est: 32.62B (-9.5%)
|
35.05B
34.68B – 35.37B
+7.4% YoY
|
38.33B
37.46B – 39.12B
+9.4% YoY
|
42.06B
40.41B – 43.58B
+9.7% YoY
|
45.77B
45.52B – 46.03B
+8.8% YoY
|
52.95B
51.29B – 54.48B
+15.7% YoY
|
| EBIT |
6.97B
est: 9.04B (-23.0%)
|
10.29B
est: 8.11B (+26.9%)
|
9.52B
est: 13.80B (-31.0%)
|
11.15B
est: 12.45B (-10.4%)
|
12.82B
est: 12.29B (+4.3%)
|
15.48B
est: 13.61B (+13.7%)
|
17.72B
est: 12.81B (+38.3%)
|
19.45B
est: 18.54B (+4.9%)
|
19.61B
est: 22.28B (-12.0%)
|
19.48B
est: 21.41B (-9.0%)
|
22.39B
est: 18.85B (+18.8%)
|
22.84B
est: 20.60B (+10.8%)
|
23.03B
est: 22.59B (+1.9%)
|
28.59B
est: 28.71B (-0.4%)
|
28.00B
est: 29.64B (-5.5%)
|
31.85B
31.51B – 32.14B
+7.4% YoY
|
34.82B
34.04B – 35.55B
+9.4% YoY
|
38.21B
36.72B – 39.60B
+9.7% YoY
|
41.59B
41.36B – 41.82B
+8.8% YoY
|
48.11B
46.61B – 49.50B
+15.7% YoY
|
| Net Income |
5.15B
est: 6.02B (-14.5%)
|
7.27B
est: 6.58B (+10.5%)
|
7.96B
est: 9.91B (-19.7%)
|
7.60B
est: 9.58B (-20.7%)
|
9.07B
est: 8.48B (+7.0%)
|
8.28B
est: 9.76B (-15.2%)
|
13.04B
est: 8.73B (+49.3%)
|
16.34B
est: 13.64B (+19.8%)
|
23.42B
est: 17.13B (+36.7%)
|
14.97B
est: 22.62B (-33.8%)
|
17.21B
est: 15.13B (+13.8%)
|
17.83B
est: 16.53B (+7.9%)
|
17.02B
est: 18.13B (-6.1%)
|
-5.61B
est: -4.29B (-30.8%)
|
18.52B
est: 19.81B (-6.5%)
|
21.34B
19.84B – 22.84B
+7.7% YoY
|
24.42B
22.82B – 25.84B
+14.4% YoY
|
28.55B
26.55B – 33.14B
+16.9% YoY
|
31.85B
29.93B – 33.85B
+11.6% YoY
|
—
— – —
-100.0% YoY
|
| SGA |
—
est: 6.69B (-100.0%)
|
—
est: 10.50B (-100.0%)
|
19.84B
est: 14.50B (+36.8%)
|
24.16B
est: 19.98B (+20.9%)
|
20.30B
est: 29.18B (-30.4%)
|
18.57B
est: 28.59B (-35.1%)
|
19.96B
est: 26.33B (-24.2%)
|
21.66B
est: 28.62B (-24.3%)
|
22.17B
est: 30.88B (-28.2%)
|
20.61B
est: 29.55B (-30.3%)
|
21.79B
est: 29.40B (-25.9%)
|
21.61B
est: 32.13B (-32.7%)
|
23.66B
est: 35.23B (-32.8%)
|
29.63B
est: 27.69B (+7.0%)
|
29.13B
est: 42.35B (-31.2%)
|
30.72B
30.39B – 31.00B
-27.5% YoY
|
33.59B
32.83B – 34.29B
+9.4% YoY
|
36.86B
35.42B – 38.20B
+9.7% YoY
|
40.12B
39.89B – 40.34B
+8.8% YoY
|
46.40B
44.95B – 47.75B
+15.7% YoY
|
| EPS |
5.37
est: 4.90 (+9.6%)
|
7.45
est: 6.18 (+20.5%)
|
7.80
est: 7.12 (+9.5%)
|
7.44
est: 7.74 (-3.9%)
|
8.88
est: 8.98 (-1.1%)
|
8.10
est: 11.29 (-28.3%)
|
12.77
est: 12.63 (+1.1%)
|
15.99
est: 14.39 (+11.1%)
|
22.91
est: 15.28 (+49.9%)
|
14.64
est: 15.37 (-4.7%)
|
16.83
est: 16.86 (-0.2%)
|
17.44
est: 17.95 (-2.9%)
|
16.65
est: 17.13 (-2.8%)
|
-5.48
est: -4.19 (-30.7%)
|
18.11
est: 19.39 (-6.6%)
|
21.00
19.38 – 22.32
+8.3% YoY
|
24.15
22.30 – 25.25
+15.0% YoY
|
28.10
25.94 – 32.39
+16.3% YoY
|
31.37
29.25 – 33.08
+11.7% YoY
|
—
— – —
-100.0% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-07 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Vanguard Emerging Markets Ex-China ETF VEXC | 0.05% | 129.5K | 0.07% |
| 2 | Schwab Emerging Markets Equity ETF SCHE | 0.04% | 5.44M | 0.06% |
| 3 | Vanguard FTSE Emerging Markets ETF VWO | 0.04% | 57.76M | 0.06% |
| 4 | Vanguard ESG International Stock ETF VSGX | 0.01% | 851.4K | 0.10% |
| 5 | Vanguard FTSE All-World ex-US ETF VEU | 0.01% | 10.05M | 0.04% |
| 6 | Vanguard Total International Stock ETF VXUS | 0.01% | 62.80M | 0.05% |
| 7 | Vanguard Total World Stock ETF VT | 0.00% | 3.50M | 0.06% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Sudhir Sitapati | Chief Executive Officer, MD & Director | 351M | male |
| Nisaba Adi Godrej | Executive Chairperson | 69M | female |
| Rajesh Tiwari | Head of Product Supply Organization (India & SAARC) | 5M | male |
| Divya Narayana Murthy | Head of Legal | — | female |
| Subha Sreenivasan Iyer | Head of Group Media | — | female |
| Tejal Virendra Jariwala | Company Secretary & Compliance Officer | — | female |
| Aasif Huseini Malbari | President of GAUM & Global Chief Financial Officer | — | male |
| Vaibhav Ram | Global Head of HR | — | male |
| Anirudh Singh | Head of NBD & Incubation | — | male |
| Darshan Gandhi | Head Design | — | female |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for GODREJCP.NS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
